Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Greten

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
JCI Insight|June 24, 2024
Innate protection against intrarectal SIV acquisition by a live SHIV vaccineYongjun Sui, Thomas J Meyer, Christine M Fennessey, et al.
The Lancet. Oncology|May 24, 2014
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trialDavid Malka, Pascale Cervera, Stéphanie Foulon, et al.
Cell Reports|November 19, 2023
Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencingAmanda J Craig, Maruhen A Datsch Silveira, Lichun Ma, et al.
Journal of Hepatology|November 7, 2016
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G Duffy, Susanna V Ulahannan, Oxana Makorova-Rusher, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
The Gut Microbiome Controls Liver Tumors via the Vagus NerveKylynda C Bauer, Rajiv Trehan, Benjamin Ruf, et al.
Hepatology (Baltimore, Md.)|December 23, 2018
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract CancerChangqing Xie, Austin G Duffy, Donna Mabry-Hrones, et al.
The New England Journal of Medicine|July 25, 2008
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
Journal for Immunotherapy of Cancer|September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer|September 14, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinomaTim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocolJack H Victory, Emily C Smith, Carrie E Ryan, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
JCI Insight|June 24, 2024
Innate protection against intrarectal SIV acquisition by a live SHIV vaccineYongjun Sui, Thomas J Meyer, Christine M Fennessey, et al.
The Lancet. Oncology|May 24, 2014
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trialDavid Malka, Pascale Cervera, Stéphanie Foulon, et al.
Cell Reports|November 19, 2023
Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencingAmanda J Craig, Maruhen A Datsch Silveira, Lichun Ma, et al.
Journal of Hepatology|November 7, 2016
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G Duffy, Susanna V Ulahannan, Oxana Makorova-Rusher, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
The Gut Microbiome Controls Liver Tumors via the Vagus NerveKylynda C Bauer, Rajiv Trehan, Benjamin Ruf, et al.
Hepatology (Baltimore, Md.)|December 23, 2018
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract CancerChangqing Xie, Austin G Duffy, Donna Mabry-Hrones, et al.
The New England Journal of Medicine|July 25, 2008
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
Journal for Immunotherapy of Cancer|September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer|September 14, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinomaTim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocolJack H Victory, Emily C Smith, Carrie E Ryan, et al.
Pageof 23